suggests that Gal-1hiexpression in HRS cells is an important negative regulator of HL tumour-associated EBV antigen-specific CD8+ T-cell immunity in cHL, and thus enables HRS cells to avoid T cell dependent immune assault129
suggests that Gal-1hiexpression in HRS cells is an important negative regulator of HL tumour-associated EBV antigen-specific CD8+ T-cell immunity in cHL, and thus enables HRS cells to avoid T cell dependent immune assault129. The presence of EBV in HL is definitely associated with several clinicopathological characteristics: It is more frequent in instances with mixed SCH-527123 […]